In today’s world, we spend most of our day in front of a screen, be it a phone, laptop or computer. While what we’re doing may be productive, overusing technology may have a negative effect on mental health. This is why undergoing a digital and/or social detox to help disconnect from technology may be beneficial. Here’s what you need to know about media detoxes.
What are social media and digital detoxes, and why should you detox?
A social media detox is when an individual refrains from using or engaging with social media for a set period, or indefinitely, to improve their well-being and mental health.
A digital detox is when someone totally refrains from or intentionally decreases the amount of time spent using all electronic devices, including tablets, TVs, computers and smartphones. During a digital detox, individuals usually avoid watching TV, playing video games, and sending text messages and emails as well as the use of all other electronic devices.
Various studies have found that social media detoxes not only improve an individual’s overall well-being and reduce anxiety, they also improve sleep and productivity as well as bring about positive changes in mood.
Social media may be useful for a lot of things. But while there are advantages to its use, there are also some disadvantages. For instance, social media has been linked to increases in levels of depression and anxiety. Too much social media use also promotes unreasonable expectations, which may negatively impact an individual’s mental health.
What are some of the benefits of a digital detox?
Findings from a recent study have shown that a one-week media break can reduce levels of depression and anxiety, with causal evidence showing that even short breaks can impact an individual’s overall well-being and emotions positively.
Refraining from the use of electronic devices a few hours before you hit the sack may considerably improve quality of sleep. Not using devices before bed also decreases blue light exposure, which has been linked to disrupted sleep.
Scrolling through social media mindlessly and checking notifications on your smartphone consumes a lot of time. Eliminating any distractions affords people more time to focus on their responsibilities and tasks at hand.
A study conducted in 2019 found that smartphones modified how people interacted socially, with researchers noting that individuals were less likely to smile at another person when they had their phones present. To stay engaged with people around you and get to know them, put your phone aside.
Unfortunately for some people who have already been diagnosed with mental illness, a digital detox may be too little, too late. Such people may in the future be better served by the novel treatments that are currently being developed by many companies, including Cybin Inc. (NYSE American: CYBN) (NEO: CYBN), which is evaluating the use of psychedelics in the treatment of mental health.
NOTE TO INVESTORS: The latest news and updates relating to Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) are available in the company’s newsroom at https://ibn.fm/CYBN
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.biomedwire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
UCLA researchers have developed a smart pen that can detect Parkinson’s during its early stages…
Clene Inc. reported new preclinical data on its drug candidate CNM-Au8 for Parkinson’s disease. The…
Proprietary machine-learning reconstruction algorithm trained on 15 years of breast CT data positions IzoView to…
Company releases report updating status of proprietary 12-lead ECG synthesis software for arrhythmia assessment. Earlier…
Researchers at University of Pittsburg have found that patients who consume sucralose regularly have a…
Exclusive U.S. patent rights for computer-aided diagnosis (“CADx”) with breast CT secured through a global…